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BLOOD GAS MANAGEMENT 
AND DEGREE OF COOLING: 
EFFECTS ON CEREBRAL 
METABOLISM BEFORE AND 
AFTER CIRCULATORY 
ARREST 
This study investigated the effects of different cooling strategies on cerebral 
metabolic response to circulatory arrest. In particular, it examined the 
impact of blood gas management and degree of cooling on cerebral metabolism 
before and after deep hypothermic irculatory arrest. Sixty-nine 1-week-old 
piglets (2 to 3 kg) were placed on cardiopulmonary b pass (37 ° C) at 100 ml/kg 
per minute. Animals were cooled to 18 ° or 14 ° C as follows: alpha-star strategy 
to 18 ° C (n = 9) or 14 ° C (n = 6), pH=stat strategy to 18 ° C (n = 9) or 14 ° C (n = 
7), or pH-stat strategy for 18 minutes followed by a switch to alpha-stat 
strategy for the last 5 minutes of cooling to 18 ° C (n = 12) or 14 ° C (n = 10). 
Animals underwent 60 minutes of circulatory arrest followed by rewarming 
with alpha-stat strategy to 36 ° C. Control animals were cooled with 
alpha-stat strategy to 18 ° C (n = 10) or 14 ° C (n = 3) and then maintained 
on cold cardiopulmonary bypass (100 ml/kg per minute) for 60 minutes. 
Three animals were excluded (see text). With the use of xenon 133 clearance 
methods, cerebral blood flow was measured at the following points: point I, 
cardiopulmonary b pass (37 ° C); point II, cardiopulmonary b pass before 
circulatory arrest or control flow (18 ° or 14 ° C); and point II I, cardiopul- 
monary bypass after rewarming (36 ° C). Cerebral metabolic rate of oxygen 
consumption was calculated for each point. At point II, cerebral metabo- 
lism was more suppressed at 14°C compared with that at 18 ° C. At any 
given temperature (18 ° or 14 ° C), pH-stat strategy provided the greatest 
suppression of cerebral metabolism. In control animals, cerebral metabolic 
oxygen consumption at point I I I  returned to baseline values after 60 
minutes of cold bypass. Sixty minutes of circulatory arrest resulted in a 
significant reduction in cerebral metabolic oxygen consumption at point I I I  
compared with that at point I regardless of cooling temperature or blood 
gas strategy. The amount of cerebral metabolic recovery was significantly 
reduced in the pH-stat 14 ° C group compared with that in the pH-stat 18 ° C 
group at point II I. The use of pH-stat strategy followed by a switch to 
alpha-stat at 14 ° C provided better cerebral metabolic recovery compared 
with either strategy used alone. The use of pH-stat strategy during initial 
cooling may provide the animal with maximal cerebral metabolic suppres- 
sion. The cerebral acidosis produced with pH-stat cooling may worsen 
cerebral metabolic injury from circulatory arrest, but this effect is elimi- 
nated with the use of alpha-stat just before the period of circulatory arrest. 
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D eep hypothermic irculatory arrest (DHCA) is often used during the repair of complex congen- 
ital heart disease in neonates. Transient and perma- 
nent neuropsychologic injury may be observed after 
DHCA. 1-3 The optimal goal during active cooling 
before a period of DHCA is to uniformly deliver 
cold perfusate to the brain so that there is a 
homogeneous reduction in temperature and meta- 
bolic activity. The reduction of cerebral metabolic 
rate of oxygen consumption (CMRO2) at the start of 
DHCA is crucial for maintenance of energy stores 
and organ protection. 4 
Strategies during the cooling phase that would 
result in the lowest CMRO 2 before DHCA may 
provide the best cerebral protection. Two such 
strategies are the use of more profound hypother- 
mia and the use of pH-stat blood gas management. 
Because CMRO2 is exponentially related to temper- 
ature during hypothermic ardiopulmonary bypass 
(CPB), 5 the use of more profound hypothermia 
during cooling may provide better global suppres- 
sion of CMROa before DHCA. Alpha-stat and 
pH-stat are blood gas management s rategies used 
to regulate arterial carbon dioxide tension (Paco2) 
during hypothermia. Alpha-stat strategy maintains a
Paco 2 level of 40 mm Hg when measured by the gas 
analyzer at 37°C (temperature uncorrected). The 
pH-stat strategy uses the addition of carbon dioxide 
to the oxygenator gas flow during cooling to achieve 
a Paco2 level of 40 mm Hg when corrected to the 
patient's core temperature (temperature corrected). 
This addition of carbon dioxide causes increased 
cerebral blood flow (CBF) during hypothermic 
CPB. 6-9 The advantages of the use of alpha-stat 
when compared with pH-stat management are more 
optimal buffering capacity and enzymatic function, 1° 
preservation of flow metabolism coupling, 6 and re- 
duction in progressive tissue acidosis during and 
after a period of DHCA. I~ The advantages of alpha- 
stat strategy may be outweighed by less effective 
cooling of the brain and therefore less suppression 
of cerebral metabolism at the start of ischemia. 
This study examined the effects of blood gas 
management (alpha-stat and pH-stat) and degree of 
cooling (14 ° and 18 ° C) on cerebral metabolism 
before and after a 60-minute period of DHCA. The 
techniques used in this investigation were designed 
to duplicate those used in the clinical setting. 
Methods 
Animal preparation. Sixty-nine 1-week-old piglets weigh- 
ing 2 to 3 kg were studied with approval of the institution's 
Animal Care and Use Committee and in compliance with 
the "Guide for the Care and Use of Laboratory Animals" 
published by the National Institutes of Health (NIH 
Publication No. 85-23, revised 1985). Animals were pre- 
medicated with intramuscular ketamine (20 mg/kg) and 
intubated and the lungs mechanically ventilated (infant 
ventilator; Sechrist Industries, Anaheim, Calif.). Methyl- 
prednisolone (40 mg/kg) was given intravenously. After a 
bolus of intravenous fentanyl (100/xg) and pancuronium 
(0.1 mg/kg), anesthesia was maintained with continuous 
fentanyl infusion (50 k~g" kg -1" hr-1) • A femoral artery 
catheter was placed for measurement of mean arterial 
pressure and arterial blood gas sampling. Temperature 
probes were placed in the nasopharynx and cortical region 
of the brain and a median sternotomy was performed. A 
burr hole was made in the skull at the crus of the sagittal 
and coronal sutures to allow sagittal sinus blood sampling. 
Method of CBF measurement. Hemispheric CBF was 
measured by the xenon (133Xe) clearance technique pre- 
viously described by this group and others. 12' 13 Two 
extracranial 16 mm cadmium telluride gamma emission 
detectors were placed over the right and left temporal 
lobes. Radioactive xenon (1.5 mCi in 2 ml of normal saline 
solution) was injected into the aortic cannula and radio- 
active decay recorded from each hemisphere over a 
5-minute period. With use of a modification of the initial 
slope index method, CBF was determined. 14 By this 
method, CBF = (slope)(A)(100), where slope is the 
natural ogarithm of the 133Xe clearance 1 minute after 
the peak of the curve, A is the tissue-blood partition 
coefficient for xenon corrected for hematocrit and tem- 
peratur@ s and 100 converts milliliters times grams -1 
times minutes -~ to milliliters times 100 gm -1 times 
minutes-1. Global CBF was determined from the average 
of the individually calculated hemispheric blood flow 
values. The baseline 133Xe value was measured before 
each determination and subtracted to correct curves for 
residual xenon. This method has recently been validated 
during hypothermic CPB. 13 
Perfusion technique. A St6ckert-Shiley (Irvine, Calif.) 
Computer Assisted Perfusion System nonpulsatile roller 
pump and a Cobe VP-CML (Denver, Colo.) membrane 
oxygenator with venous reservoir comprised the CPB 
circuit. Circuit blood gas values were monitored with a 
CDI-300 (CDI; 3M Healthcare, Irvine, Calif.) continuous 
in-line blood gas analyzer. The circuit was primed with 
fresh heparinized onor pig whole blood with a hemato- 
crit value of 26% -+ 0.3%. After animals were heparinized 
(500 U/kg), an 8F arterial and a 14F venous cannula were 
inserted in the ascending aorta and right atrium, respec- 
tively, and CPB initiated. Pump flow was maintained at a 
constant flow rate of 100 ml. kg- 1 • min 1 throughout the 
duration of CPB. Pharmacologic agents were not admin- 
istered to control blood pressure during CPB. Sodium 
bicarbonate was given to maintain abase excess between 
-3  and 3 mmol/L. The Paco a was maintained at a prede- 
termined level according to the study protocol by adjusting 
the gas flow rate in the oxygenator with the addition of 5% 
CO 2 as necessary during the period of hypothermic CPB. 
Study protocol. A schematic diagram of the experimen- 
tal protocol and data collection sequence is shown in Fig. 
1. After instrumentation, animals were placed on CPB 
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(37.2 ° + 0.1 ° C) at 100 ml/kg per minute and baseline 
measurements (point I) were obtained. Animals were 
cooled to 18.4 ° -+ 0.1 ° C or 1410 ° _+ 0.2 ° C over 23 minutes 
and data (point II) were obtained. The experimental 
groups were cooled as follows: the cff18 ° C) group re- 
ceived alpha-star strategy to 18 ° C (n = 9); the pH(18 ° C) 
group received pH-stat strategy to 18°C (n = 9); the 
pH-+cffl8 ° C) group received pH-stat strategy for 18 
minutes followed by a switch to alpha-stat strategy for the 
last 5 minutes of cooling to 18 ° C (n = 12); the o~(14 ° C) 
group received alpha-stat strategy to 14°C (n = 6); the 
pH(14 ° C) group received pH-stat strategy to 14 ° C (n = 
7); and the pH-->a(14 ° C) group received pH-stat strategy 
for 18 minutes followed by a switch to alpha-stat strategy 
for the last 5 minutes of cooling to 14°C (n = 10). 
Alpha-stat strategy was defined as the maintenance of 
Paco a at 40 - 5 mm Hg, temperature uncorrected, and 
pH-stat as maintenance of Paco a at 40 _+ 5 mm Hg, 
temperature corrected. Animals underwent 60 minutes of 
DHCA followed by rewarming with alpha-stat strategy to 
36.4 ° _+ 0.1°C over 26 _+ 1 minutes and final measure- 
ments were obtained uring CPB (point III). Not shown 
in this schematic are control animals that were cooled with 
alpha-stat strategy to 18 ° C (group CTL[18 ° C], n = 10) or 
14 ° C (group CTL[14 ° C], n = 3) followed by 60 minutes 
of deep hypotbermic CPB at 100 ml/kg per minute. The 
duration of CPB for animals undergoing DHCA was 84 + 
I minutes and 149 + 3 minutes for those undergoing deep 
hypothermic CPB. 
Nasopharyngeal and cortical brain temperatures, mean 
arterial pressure, arterial and sagittal sinus blood gas 
values, hemoglobin concentration, and CBF were mea- 
sured at each stage. The cerebral arteriovenous oxygen 
content difference (cCa-vo2) was then calculated as Cao2 
- Csso2, where Cao a is the arterial oxygen content and 
Csso2 is the sagittal sinus oxygen content. A GEM-STAT 
blood gas/electrolyte monitor (Mallinckrodt, Ann Arbor, 
Mich.) was used to measure blood gas values. Oxygen 
saturation and hemoglobin were measured by an IL482 
Co-Oximeter system (Instrumentation Laboratory, Lex- 
ington, Mass.). Cerebral metabolism (CMRO2), cerebral 
oxygen delivery (cD. 02), and cerebral oxygen extraction 
ratio (co2ER) were calculated as follow~: 
CMROz(ml - 100 gm brain - 1 . min - 1) = (cCa-vo2)(CBF) 
cD • O2(ml  02  • 100 gm brain- 1 , min  1) = (Cao2)(CBF) 
eO2ER (%) = CMRO(cD • 0 2 
Statistical analysis. Data were analyzed by the Stu- 
dent's paired t test to compare results within each group. 
The unpaired t test and analysis of variance were used to 
compare results between groups. All results are expressed 
as means plus or minus the standard errors. Significance 
was defined as p < 0.05. 
Results 
The study was successfully completed in 66 of  the 
69 animals. Three animals were excluded, two be- 
37°~ 
18°( 
14°C 
[ExC27a'"72o:. . . . . . . . . .  
1 n III 
Fig. 1. Experimental protocol and data collection se- 
quence. After instrumentation, animals were placed on 
CPB at 100 ml/kg per minute and 37°C and baseline 
measurements (I) were obtained. Animals were cooled to 
18 ° or 14 ° C over 23 minutes and data (II) were obtained. 
Experimental groups were cooled as follows: cff18°C), 
alpha-stat strategy to 18°C (n = 9); pH(18 ° C), pH-stat 
strategy to 18 ° C (n -- 9); pH-+c~(18 ° C), pH-stat strategy 
for 18 minutes followed by switch to atpha-stat s rategy for 
last 5 minutes of cooling to 18°C (n = 12); cffl4 ° C), 
alpha-stat strategy to 14°C (n = 6); pH(14 ° C), pH-stat 
strategy to 14 ° C (n = 7); pH-->cff14 ° C), pH-stat strategy 
for 18 minutes followed by switch to alpha-stat s rategy for 
last 5 minutes of cooling to 14°C (n = 10). Animals 
underwent 60 minutes of DHCA followed by rewarming 
to 36 ° C over 26-minute period. Final measurements were 
obtained at this time (III). Not shown in this schematic are 
control animals, which were cooled with alpha-stat strat- 
egy to 18 ° C (CTL[18 ° C], n = 10) or 14 ° C (CTL[14 ° C], 
n = 3) followed by 60 minutes of deep hypothermic CPB 
(100 ml/kg per minute). 
cause of markedly  abnormal  basel ine CMRO 2 val- 
ues (groups pH[18 ° C] and ~[14 ° C]) and one be- 
cause of the inabil ity to adequately rewarm to a 
nasopharyngeal  temperature  of 36 ° C within 30 min- 
utes after reinst itut ion of CPB (group pH[18 ° C]). 
Summary data for all animals are shown in Tables 
I through IV. For  simplicity, statistical significance is
designated in tables only for selected variables. 
Control  data.  There were no significant differ- 
ences in arterial  or sagittal sinus pH or Pco 2 values, 
mean arterial  pressure, nasopharyngeal  tempera-  
ture, or cerebral  oxygen extraction ratio between 
stage I and stage III. In the CTL(18 ° C) animals 
after rewarming after 60 minutes of deep hypother-  
mic CPB (stage I I I )  there was a significant decrease 
in CBF compared  with that in stage I. CMRO2 
returned to basel ine values in all animals regardless 
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Table I. Summary data for all animals 
18 ° C 14 ° C 
CTL a pH pH--~a CTL a pH pH--~ez 
NPT (°C) 
I 37.4 + 0.1 37.5 + 0.2 37.0 -+ 0.2 37.2 _+ 0.2 37.4 -+ 0.6 36.8 _+ 0.2 37.1 ± 0.2 37.4 +_ 0.3 
II 18.4 _+ 0.3 18.6 -+ 0.2 18.4 ± 0.2 18.1 -+ 0.1 14.5 ± 0.3 13.6 _+ 0.3 13.6 + 0.3 14.3 + 0.3 
III 36.9 + 0.3 36.7 + 0.3 36.6 + 0.3 35.9 + 0.3 35.8 +_ 0.1 37.0 ± 0.0 36.1 +_ 0.1 36.4 ± 0.2 
Brain T (°C) 
I 36.8 _+ 0.3 37.1 -+ 0.5 34.9 +- 0.4*t 37.1 + 0.35 37.9 +_ 0.5 35.3 _+ 0.5*4 36.3 _+ 0.6 37.4 + 0.4 
II 21.2 _+ 0.5 21.2 ± 0.6 21.6 ± 0.6 19.3 +_ 0.4*% 17.1 _+ 0.6 17.8 +_ 1.2 16.5 _+ 0.8 17.6 _+ 1.1 
III 34.4 _+ 0.4§ 33.8 +_ 0.8§ 31.7 -+ 0.6*t§ 32.9 _+ 0.6§ 33.6 _+ 1.2 33.5 -+ 0.7 33.2 _+ 1.0§ 33.4 _+ 0.9§ 
MAP (ram Hg) 
I 62+_8 55-+5 46 +6 38-+2 33_+1 45_+6 46±2 45_+4 
II 83+_6 69-+5 66±6 61-+4 57_+1 65-+8 63+4 57+-4 
III 70 _+ 9 55 -+ 7 53 ± 8 49 -+ 3 45 +_ 5 58 ± 9 57 ± 4 58 -+ 6
HCT (%) 
I 26-+1 26±1 27 +1 26-+1 25-+1 26 +1 27_+2 27-+0 
II 26+1 25-+1 27 +1 26+-1 25-+2 25-+1 27-+2 27 +1 
III 33-+2§ 27-+1" 28±1"  27-+1" 30-+1 27-+1 26-+2 28-+1 
Values given as mean plus or minus standard error. CTL, Control; a, alpha-stat;pH, pH-stat;pH--->a, pH-stat switched to alp a-stat;/, CPB (37 °C); II, CPB 
(18 ° or 14 ° C); III, CPB (36 °C); NPT, nasopharyngeal temp; Brain T, cortical temp; MAP, mean arterial pressure; HCT, hematocrit. 
*p < 0.05, all groups versus control. 
tP < 0.05, all groups versus a(18 ° C).
:~p < 0.05, all groups versus pH(18 ° C). 
§p < 0.05, stage III versus stage I. 
Table II. Arterial and sagittal sinus blood gas data for animals cooled to 18 ° C 
CTL a pH pH---->c~ 
apH 
I 7.40 --_ 0.01 7.39 + 0.15 7.41 -+ 0.01 7.40 _+ 0.01 
II 7.38 + 0.02 7.34 + 0.13 7.13 -+ 0.02*t~- (7.40 _+ 0.02) 7.09 _+ 0.01"~ (7.37 ± 0.01)-~7.35 + 0.01 
III 7.41 + 0.01 7.38 ± 0.01 7.40 + 0.01 7.39 _+ 0.01 
Paco a (ram Hg) 
I 38+_1 37±1 38-+1 38_+1 
II 40 +~ 2 44 _+ 2 83 -+ 7*% (36 +_ 2) 93 _+ 3*t (37 _+ 1)-->42 _+ 1 
III 38_+1 37±1 37-+0 39_+1 
sspH 
I 7.29 + 0.01 7.27 _+ 0.01 7.27 +- 0.02 7.27 -+ 0.01 
II 7.30 2 0.02 7.25 _+ 0.01 7.08 -+ 0.01*% 7.05 -+ 0.01--->7.27 + 0.01§ 
III 7.32 _+ 0.02 7.27 + 0.02 7.23 + 0.02 7.25 _+ 0 02
Pssco 2 (mm Hg) 
I 55 -2  55--_1 56-2  56-+1 
II 50 _+ 2 56 ± 2 95 -+ 2"t$ 102 +_ 2--->53 _+ 1§ 
II I  52 ± 2 56 2 5 60 ± 3 57 -+ 2 
Values given as mean plus or minus standard error. Temperature-uncorrected values given with temperature-corrected values in parentheses. CTL, Control 
(60 minutes deep hypothermic CPB); c~, alpha-stat; p//, pH-stat; pH-oa, pH-stat switched to alpha-stat; I, CPB (37 ° C); II, CPB (18 ° or 14 ° C); III, CPB 
(36 ° C); apH, arterial pH; sspH, sagittal sinus pH; Psscoz sagittal sinus carbon dioxide tension. 
*p < 0.05, all groups versus control. 
tp < 0.05, all groups versus a(18 ° C).
Sp < 0.05, all groups versus a(14 ° C).
§p < 0.05, all groups versus pH(18 ° C).
of final cooling temperature (18 ° or 14 ° C) after 
rewarming. It is also interesting to note that 
CMRO 2 returned to baseline values even though 
there was a significant decrease in cortical brain 
temperature in CTL(18 ° C) group animals at stage 
III after rewarming compared with that in stage I. 
There was a significant increase in hematocrit con- 
centration in the CTL(18 ° C) group at stage III 
compared with that at stage I; however, this increase 
was not believed to be large enough to account for 
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Table IIL Arterial and sagittal sinus blood gas data for animals cooled to 14 ° C 
CTL c~ pH pH-*a  
apH 
I 7.38 ± 0.02 7.39 ± 0.02 7.40 _~ 0.01 7.38 _+ 0.01 
I I  7.40 ± 0.03 7.38 ± 0.01 6.95 ± 0.03"?:)§ (7.29 _+ 0.01) 7.01 ± 0.01*:)il (7.35 ± 0.01)---~7.38 ± 0.02 
I I I  7.43 ± 0.02 7.40 ± 0.01 7.41 ± 0.02 7.42 _+ 0.01 
Paco2 (ram Hg) 
I 39±3 40_+2 40±1 39_+ 1 
I I  39 _+ 4 42 ± 1 133 ± 8"?$§ (43 ± 3) 123 ± 4*:) (41 ± 1)--+39 ± 2 
II1 37±0 37±1 39 +1 38±1 
sspH 
I 7.26 ± 0.02 7.23 + 0.01 7.27 _* 0.01 7.28 _+ 0.02 
II 7.32 ± 0,02 7.30 ± 0.01 6.92 + 0.03"?:)§ 6.99 +_ 0.01-->7.27 ± 0.0111 
I I I  7.31 ± 0.03 7.27 ± 0.00 7.28 +_ 0.02 7.29 ± 0.01 
Pssco2 (mm Hg) 
I 6l  ±3  61±1 56_  +1 60_+1 
I I  50 ± 4 50 ± 2 131 _+ 7*t:)§ 123 ± 3-->53 ± 21i 
I I I  54 ± 3 52 ± 2 56 _+ 3 57 _+ 3 
Values given as mean plus or minus standard error. Temperature-uncorrected values given with temperature-corrected values in parentheses. CTL, Control 
(60 minutes deep hypothermic CPB); cq alpha-stat; pH, pH-stat; pH--+ce; pH-stat switched to alpha-stat;/, CPB (37 ° C); IL. CPB (18 ° or 14 ° C); II[, CPB 
(36 ° C); apH,, arterial pH; sspH, sagittal sinus pH; Pssco2, sagittal sinus carbon dioxide tension. 
*p < 0.05, all groups versus control. 
tp < 0.05, all groups versus a(18 ° C). 
~+p < 0.05, all groups versus ee(14 ° C). 
§p < 0.05, all groups versus pH(18 °C). 
I~p < 0.05, all groups versus pH(14 °C). 
Table IV. Summary data .for all animals 
18 ° C 14 ° C 
CTL ce pH pH-+a CTL c~ pH pH--->c~ 
CBF (ml/100 gin/rain) 
I 38.8 ± 2.0 36.0 ± 2.3 32.1 ± 1.8" 30.4 _+ 0.8"? 26.4 ± 1.0 32.4 ± 2.5 34.7 _+ 1.1" 31.4 ± 1.4 
I I  35.8 ± 2.0 32.6 _+ 2.7 27.4 ± 2.1 28.6 ± 1.0 26.0 + 1.9 28.5 ± 3.2 33.7 _+ 1.8" 26.5 + 1.2 
I I I  31.0 + 3.4:) 30.2 _+ 2.0:) 23.9 ± 1.0:) 24.0 _+ 0.7*:) 22.l ± 0.8 26.1 ± 1.5:) 25.9 ± 1.2:) 27.3 ± 1.1:) 
CMRO2 (ml/100 gm/min) 
I 3.01 ± 0.13 3.06 ± 0.13 2.79 _+ 0.12 2.65 + 0.10"? 2.68 _+ 0.18 2.52 ± 0.137 2.74 ± 0.14 2.71 ± 0.10 
I I  1.19 + 0.08 1.30 _+ 0.30 1.05 _+ 0.06t§ 0.83 + 0.05"[[ 0.94 ± 0.17 0.80 ± 0.06? 0.56 -+ 0.06"?§11 0.75 ± 0.05~ 
I I I  2.97 ± 0.21 2.30 ± 0.20*:) 2.26 _+ 0.09".~§ 2.08 _+ 0.11":) 2.66 _+ 0.14 1.91 -+ 0.06*:) 1.91 ± 0.11":)1[ 2.35 ± 0.08.2§¶ 
cosER (%) 
I 64.7 ± 3.5 68.3 ± 2.1 67.7 ± 3.0 69.0 _+ 2.2 82.3 _+ 1.7 64.6 + 4.9 62.3 ± 1.8 65.4 ± 1.1 
I I  25.9 ± 2.1 31.2 ± 2.9 25.9 ± 1.8 22.4 ± 1.5 27.3 ± 4.9 22.9 ± 3.2 12.5 ± 1.4"t§[[ 20.7 ± 2.1¶ 
I I I  62.5 ± 4.6 66.2 ± 3.9 70.5 ± 3.1 65.7 ± 2.4 82.0 ± 1.6 58.4 ± 4.8 60.3 ± 4.8 62.8 ± 1.9 
Values given as mean plus or minus standard error. CTL, Control; a, alpha-stat;pH, pH-stat;pH~a, pH-stat switched to alpha-stat;/, CPB (37 ° C); I/; CPB 
(18 ° or 14 ° C); III, CPB (36 ° C); co2ER, cerebral oxygen extraction ratio. 
*p < 0.05, all groups versus control. 
tP < 0.05, all groups versus a(18 ° C). 
Sp < 0.05, stage III versus tage I. 
§p < 0.05, all groups versus a(14 ° C). 
lip < 0.05, all groups versus pH(18 °C). 
¶p < 0.05, all groups versus pH(14 °C). 
the return of CMRO 2 to baseline levels in these 
animals. 
Effects of cooling temperature on CMRO2. Cor- 
tical brain temperatures were significantly lower in 
those groups of animals cooled to 14 ° C versus those 
cooled to 18 ° C. At stage II (Fig. 2), CMRO 2 was 
significantly more suppressed at 14 ° C than at 18 ° C. 
Regardless of the final cooling temperature and the 
amount of cerebral metabolic suppression at stage 
II, 60 minutes of DHCA resulted in a significant 
reduction in CMRO 2 after rewarming compared 
with baseline values (Fig. 3). 
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18QC 14°C 
Fig. 2. CMRO 2 measurements  before DHCA at maximal 
cooling (18 ° or 14 ° C). CMRO 2 is more suppressed at 
14 ° C compared with value at 18 ° C. At any given temper- 
ature (18 ~ or 14 ° C), pH-stat strategy provides better 
suppression of CMRO 2. Mean data plus or minus stan- 
dard error are shown. *p < 0.05 versus all other groups at 
maximal cooling. 
Effects of blood gas management (alpha-stat ver- 
sus pH-stat) on CMRO2. There were no significant 
differences in cortical brain temperatures at stage II 
between the c~(18 ° C) and pH(18 ° C) or a(14 ° C) 
and pH(14 ° C) groups. At any given temperature 
(18 ° or 14 ° C), pH-stat strategy provided signifi- 
cantly better suppression of CMRO2 at stage II 
compared with that with the use of alpha-stat strat- 
egy (Fig. 2). CBF decreased at stage III in groups 
c~(18 ° C), pH(18 ° C), oz(14 ° C), and pH(14 ° C) com- 
pared with that at stage I. Cerebral oxygen extrac- 
tion ratio at stage III was significantly decreased in 
the group pH(14 ° C) animals compared with that in 
the oz(18 ° C), pH(18 ° C), and o~(14 ° C) groups. 
Even though the use of pH-stat strategy provided 
the least amount of CMRO 2 at stage II, 60 minutes 
of DHCA resulted in a significant reduction of 
CMRO 2 after rewarming compared with baseline 
values in the pH(18 ° C) and pH(14 ° C) group ani- 
mals and in the ~(18 ° C) and oe(14 ° C) groups (Fig. 
3). There were no significant differences in the 
amount of cerebral metabolic recovery at stage III 
between the ~(18 ° C) and pH(18 ° C) or oe(14 ° C) 
and pH(14 ° C) groups. There was, however, a sig- 
nificant reduction in CMRO 2 at stage III in the 
a(14 ° C) and pH(14 ° C) groups compared with that 
in the pH(18 ° C) group (Fig. 3). This reduction in 
CMRO 2 at stage III was not seen when the a(18 ° C) 
and a(14 ° C) groups were compared. These reduc- 
tions in CMRO 2 may be the result of the use of such 
profound hypothermia in those animals cooled to 
14 ° C. There was a significant difference in sagittal 
sinus pH, venous carbon dioxide tension (Pvco2), 
3.5 
3 
2.5 
CMRO: 2 
(ml/100g/min) 
1.5 
1 
0.5 
0 
• Stage I [ ]  Stage II1 
CTL CTL 
18°C 14°C 
~(18°C) pH(18~C) a(14°C) pH(14°C) 
Fig. 3. CMRO 2 measurements before and after deep 
hypothermic CPB or DHCA. Control (CTL) animals had 
almost complete return of CMRO 2 to baseline values 
after deep hypothermic CPB. There was significant de- 
crease in CMRO 2 from stage ! to stage III in all animals 
undergoing 60 minutes of DHCA. Mean data plus or 
minus standard error are shown. *p < 0.05, stage III 
versus tage I; ?p < 0.05, pH(14 °C) versus pH(18 °C);/, 
CPB (37 ° C); IlL CPB (36 ° C) after rewarming. 
and Paco2 values in the pH(18 ° C) and pH(14 ° C) 
groups compared with those values in the oe(18 ° C) 
and a(14 ° C) animals (Tables II and III). Animals in 
the pH-stat groups were profoundly acidotic with 
very low pH and high Pvco 2 values, especially those 
animals cooled to 14 ° C. 
pH-->~-stat data. There was a significant increase 
in sagittal sinus pH and a significant decrease in 
sagittal sinus Pvco 2 at stage II in the pH-+o~(18 ° C) 
and pHlox(14 ° C) animals compared with respec- 
tive values in the pH(18 ° C) and pH(14 ° C) groups. 
The cortical brain temperature and CMRO2 at stage 
II were significantly lower in the pH--+o~(18 ° C)
group than these values in the c~(18°C) and 
pH(18 ° C) group animals. These differences in cor- 
tical brain temperature and CMRO 2 at stage I! did 
not occur in the pH---~o~(14 ° C) animals. CBF de- 
creased at stage III in the pH--+o~(18°C) and 
pH--+~(14 ° C) groups compared with values at stage 
I. CMRO 2 was significantly increased at stage III in 
the pH-->a(14 ° C) animals compared with this value 
in the o~(14 ° C) and pH(14 ° C) groups (Fig. 4). 
There was no significant difference in CMRO 2 at 
stage III in the pH-->c~(18 ° C) group compared with 
the value in the 0~(18 ° C) and pH(18 ° C) group 
animals. Again, 60 minutes of DHCA resulted in 
decreased CMRO 2 after rewarming compared with 
baseline values in both pH--~c~(18 ° C) and 
pH-->o~(14 ° C) groups. 
The baseline cortical brain temperatures were 
significantly lower in the pH(18 ° C) and o~(14 ° C) 
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groups; however, this was not believed to be of 
physiologic importance. The cortical brain temper- 
atures at stage III decreased significantly in the 
a(18 ° C), pH(18 ° C), pH--+o~(18 ° C), pH---~a(14 ° C), 
and pH(14 ° C) groups compared with those at stage 
I. A similar decrease in brain temperature after 
rewarming occurred in the CTL(18 ° C) animals, and 
this did not seem to affect the recovery of CMRO2 
to baseline values. Baseline CMRO 2 values in the 
pH--~a(18 ° C) and o~(14 ° C) animals were signifi- 
cantly lower compared with those in the CTL(18 ° C) 
and o~(18 ° C) groups and in the a(18 ° C) group, 
respectively. A strict study protocol was adhered to 
for each animal in regard to anesthesia and instru- 
mentation, which makes these unlikely explanations 
for these differences. The data were analyzed with 
use of the raw change in CMRO2 comparing stage I
with stage III values within groups; therefore, these 
baseline differences hould not interfere with data 
analysis. 
Discussion 
The prevalence of neuropsychologic injury occur- 
ring after DHCA for the repair of complex congen- 
ital heart defects may be as high as 25%. 2 The 
principal method of cerebral protection during 
DHCA is the use of hypothermia. Cerebral metab- 
olism decreases exponentially with reductions in 
temperature. 5 A reduction in CMROe decreases the 
depletion rate of high-energy phosphate compounds 
and the development of intracellular acidosis that 
occurs during circulatory arrest. 4' 16,17 These find- 
ings emphasize the importance of the uniform de- 
livery of cold perfusate to the brain so that a 
homogeneous reduction in cerebral temperature 
and CMRO 2 occurs at the start of DHCA. Cerebral 
metabolic recovery after DHCA may be enhanced 
by strategies that provide the least amount of cere- 
bral metabolism before DHCA. The use of lower 
cooling temperatures and use of the cerebral vaso- 
dilator CO2 (pH-stat blood gas strategy) are two 
strategies that by themselves or in combination may 
result in improved cerebral metabolic recovery after 
a period of DHCA. 
This study demonstrates in this model of neonatal 
CPB,that CMROe is more suppressed at 14 ° C than 
at 18 ° C. At any given temperature, 18 ° or 14 ° C, 
CMRO 2 is better suppressed in those animals 
cooled with pH-stat blood gas management (Fig. 2). 
Exposure to 60 minutes of DHCA, however, re- 
sulted in a significant decrease in CMRO 2 from 
3~ 
2.5 
2 
CMRO~ 1.5 
(rnl/100g/rrlin) 
1 
0.5 
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[ ]  Stage IIl 
¢x pH pH-->c~ 
d4°C) (14oc) (14oc) 
Fig. 4. CMRO2 measurements before and after DHCA 
in those animals cooled to 14 ° C. There was significant 
decrease in CMRO a from stage I to stage III in all 
animals. At stage III, there was significant decrease in 
CMRO2 in alpha-stat and pH-stat groups compared with 
values in pH--+c~-stat group animals. Mean data plus or 
minus standard error are given. *p < 0.05, stage III versus 
stage I; ?p < 0.05, pH--~a-stat versus alpha-star and 
pH-stat;/, CPB (37 ° C); III, CPB (36 ° C) after ewarming. 
baseline values after rewarming regardless of blood 
gas strategy or final cooling temperature (Fig. 3). 
Possible mechanisms for the impairment in cere- 
bral metabolic recovery after DHCA include inad- 
equate rewarming of the brain after profound hypo- 
thermia, continued consumption of oxygen by the 
brain during the arrest period, and further reduc- 
tions in intracellular pH value during the arrest 
period. The ahnost 100% recovery of CMRO2 seen 
in control animals after prolonged exposure to pro- 
found hypothermia (14 ° or 18 ° C), measured at statis- 
tically similar rewarming temperatures to those in the 
experimental groups, makes inadequate r warming of 
the brain an unlikely mechanism (Fig. 3). 
This study demonstrates that even though the use 
of pH-stat at more profound hypothermic tempera- 
tures (14 ° C) provides the least amount of cerebral 
metabolism, the brain co tinues to consume oxygen 
before and during the period of DHCA. The pres- 
ence of continued cerebral metabolism at the start 
of DHCA has been shown to occur clinically and in 
other experimental models of neonatal CPB 5' 18, ~9 
and may in part explain the impairment in CMRO a 
after DHCA. Recent investigations have demon- 
strated that 1 hour of arrest, even at deep hypother- 
mic temperatures, reduces the metabolic reserve of 
the brain. Strategies uch as topical cooling of the 
brain, intermittent perfusion, and trickle flow may 
1656 Skaryak et aL 
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help prevent further cerebral injury from occurring 
during the arrest imeJ 2' 2o 
Cerebral metabolic recovery was significantly re- 
duced in those animals cooled with pH-stat o 14 ° C 
compared with that in the pH(18 ° C) group. This 
difference was not seen in those groups cooled with 
alpha-stat strategy. At the start of DHCA, the 
pIt-stat animals were profoundly acidotic with very 
low arterial and sagittal sinus pH values and high 
Pvc% values, especially those cooled to 14 ° C (pH 
6.95 _+ 0.03, pH 6.92 -2_ 0.03, and 131 + 7 mm Hg, 
respectively). This degree of acidosis preceding 
DHCA may make the brain less tolerant of pro- 
longed ischemia despite the degree of metabolic 
suppression. A recent investigation has demon- 
strated that if a period of arrest is used in addition to 
pH-stat strategy, a further eduction occurs in intra- 
cellular pH. n The resultant severe cerebral acidosis 
may delay or prevent full brain recovery. Lower 
intracellular pH also results in an impairment in 
cellular enzymatic function. 2~ 
From the latter findings, a switch strategy was 
devised, pH-stat strategy would be used during 
initial cooling to provide maximal cerebral meta- 
bolic suppression. A switch to alpha-stat strategy 
would follow just before the period of arrest to 
decrease the severe acid debt that occurs at pro- 
found hypothermia with the use of pH-stat. The 
sagittal sinus pH and Pvco 2 values were not signifi- 
cantly different after the use of the switch strategy 
compared with those in the animals cooled to 14 ° C 
with alpha-stat strategy alone. The switch strategy 
provided significantly better recovery of cerebral 
metabolism after DHCA compared with recovery 
with either strategy used alone (pH-stat or alpha- 
stat) in those animals cooled to 14°C (Fig. 4). 
However, an impairment in cerebral metabolic re- 
covery after 60 minutes of DHCA still occurred. 
When the switch strategy was used during cooling to 
18 ° C, there was no difference in cerebral metabolic 
recovery after DHCA compared with the recovery 
with either strategy used alone. This latter finding 
may be explained by the fact that the acid debt 
accrued with the use of pH-stat at 18 ° C is not as 
large; therefore, the addition of a 60-minute period 
of DHCA may not be as deleterious. 
There are several imitations to this study. The 
cerebral metabolic response patterns demonstrated 
in these animals are acute changes only. However, 
recent investigations have demonstrated that 
DHCA is associated with an impairment in long- 
term neurologic outcome that may be related to the 
pattern of cerebral metabolic recovery seen in the 
immediate post-CPB period. 22 The measurements 
of CBF are global and do not provide information 
about regional blood flow. However, this method of 
CBF measurement was chosen to parallel methods 
used in patients at this institution to make re- 
sults produced in the laboratory setting clinically 
applicable. The brains were not examined histolog- 
ically or on a molecular level. Further studies will 
need to be done to help understand these acute 
changes in cerebral metabolism on a molecular 
level. 
In summary, this study demonstrates that 
CMRO 2 is more suppressed at 14 ° C than at 18 ° C. 
pH-stat strategy provides better suppression of ce- 
rebral metabolism at any given temperature (14 ° 
and 18 ° C). The use of pH-stat strategy during initial 
cooling to 14°C followed by a switch to alpha-stat 
strategy just before arrest results in better recovery 
of cerebral metabolism after DHCA compared with 
the recovery with either strategy used alone. Re- 
gardless of degree of cooling and blood gas strategy 
used, 60 minutes of DHCA results in an impairment 
in the recovery of cerebral metabolism after re- 
warming. The appropriateness ~ of a blood gas strat- 
egy depends on many factors including the degree of 
hypothermia, pump flow rate, the use of DHCA, 
and the presence of anatomic variants (large aor- 
topulmonary shunts): In situations in which ineffi- 
cient cooling may occur because of anatomic vari- 
ants or in which a prolonged use of DHCA is 
anticipated, the use of  lower cooling temperatures 
and the cerebrovasodilation of CO 2 may be benefi- 
cial. Once the patient is cool, however, a switch to 
alpha-stat strategy may help preserve intracellular 
pH by reducing the amount of postarrest cerebral 
acidosis. 
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